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VersatilityThe clinical use of efﬁcient therapeutic agents is often limited by the poor permeability of the biological
membranes. In order to enhance their cell delivery, short amphipathic peptides called cell-penetrating
peptides (CPPs) have been intensively developed for the last two decades. CPPs are based either on protein
transduction domains, model peptide or chimeric constructs and have been used to deliver cargoes into cells
through either covalent or non-covalent strategies. Although several parameters are simultaneously involved
in their internalization mechanism, recent focuses on CPPs suggested that structural properties and
interactions with membrane phospholipids could play a major role in the cellular uptake mechanism. In the
present work, we report a comparative analysis of the structural plasticity of 10 well-known CPPs as well as
their ability to interact with phospholipid membranes. We propose a new classiﬁcation of CPPs based on
their structural properties, afﬁnity for phospholipids and internalization pathways already reported in the
literature.: +33 4 67 52 15 59.
.
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Development of new therapeutics broadly increased during the
last years. The enhancement of the knowledge of the human genome
and its corresponding proteomes and interactomes led to innovative
strategies in the design and improvement of bioactive molecules.
However, although these bioactive agents have shown a strong ef-
ﬁciency and attractive activities, their cellular internalization still
remains the main limitation for their clinical use. Biological mem-
branes are often pointed out as the ﬁrst reason of the encountered
cellular delivery troubles because they generally constitute imper-
meable barriers for drugs. Several delivery systems have been
conceived in order to overcome the low permeability of nuclear or
plasma membranes and various methods have aimed to improve
therapeutics delivery, such as viruses and liposomes. Among them are
carrier peptides called cell-penetrating peptides (CPPs) which have
undergone a strong development during the last twenty years [1].
CPPs are generally described as short amphipathic or purely cationic
peptides of less than 30 amino acids which possess a positive net
charge, are able to penetrate biological membranes and transfer
covalently or non-covalently attached bioactive cargoes into cells [2].
More than 20 different CPPs have been described so far and wereapplied for the delivery of various cargoes. From small particles to
peptides, proteins and nucleic acids, the CPP-mediated internalization
of a cargo has been validated into a wide variety of cell types from
different tissues and organisms [3,4]. Although the efﬁciency of CPPs
has clearly been proved, their mode of action still remains puzzling.
Early on, direct translocation [5–8], endocytotic processes [9–12] or
combination of several mechanisms [13] were suggested as possible
delivery pathways for CPPs. Nowadays, the most plausible explana-
tion for the mechanism of cellular entry seems to be a complex
combination of several parameters. Understanding the cellular uptake
mechanism of CPPs constitutes a crucial factor to decipher, in order to
determine the intracellular behavior and efﬁciency of the cargo.
Several approaches have been undertaken to identify the different
parameters involved in the cellular uptake. The structural properties
as well as the interaction with membrane components such as
heparan sulfate or lipid-raft domains have been studied [11,14,15].
However, although some similar features exist between the most
efﬁcient CPPs, no clear rules can be proposed.
In the present work, we have compared the alteration in structural
state and the interaction of 10 CPPs with model membranes, in order
to classify the CPPs with regard to both their biophysical properties
and their ability to enter the cell. CPPs are usually divided into three
classes; protein transduction domains (PTDs), model peptides and
designed peptides, as shown in Table 1. PTD peptides are natural
peptides derived from speciﬁc protein fragments with transduction
abilities. This class contains the Tat-peptide corresponding to the 48–
Table 1
Sequences of the CPPs.
Origin Name Sequence aa MW [Da] Ref.
Protein Transduction Domain (PTD) Tat GRKKRRQRRRPPQ-NH2 13 1718.1 [16]
Penetratin RQIKIWFQNRRMKWKK-NH2 16 2245.1 [17]
EB1 LIRLWSHLIHIWFQNRRLKWKKK-NH2 23 3099.8 [18]
pVEC LLIILRRRIRKQAHAHSK-NH2 18 2208.8 [19]
Retro-pVEC KSHAHAQKRIRRRLIILL-NH2 18 2208.8 [19]
M918 MVTVLFRRLRIRRACGPPRVRV-NH2 22 2651.4 [20]
M1073 MVTVLFRRLRIRRASGPPRVRV-NH2 22 2635.3 [20]
Model Peptides MAP KLALKLALKALKAALKLA-NH2 18 1876.5 [21]
Arg9 RRRRRRRRR-NH2 9 1422.8 [22]
Designed Peptides TP10 AGYLLGKINLKALAALAKKIL-NH2 21 2181.8 [23]
MPG GALFLGFLGAAGSTMGAWSQPKKKRKV-Cya 27 2908.5 [24]
MPG-α GALFLAFLAAALSLMGLWSQPKKKRKV-Cya 27 3047.0 [25]
Pep-1 KETWWETWWTEWSQPKKKRKV-Cya 21 2907.4 [26]
CADY GLWRALWRLLRSLWRLLWKA-Cya 20 2653.0 [27]
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the Penetratin derived from the third helix of the Antennapedia
homeodomain (segments 43–58) [17], EB1 where certain residues of
Penetratin have been substituted by histidine [18], pVEC and retro-
pVEC variant derived from themurine cell adhesionmolecule vascular
endothelial cadherin [19], and M918 and its M1073 variant derived
from the tumor suppressor protein p14ARF (amino acids 1–22) [20].
Model peptides consist of amino-acid sequences that are generally
based on repeat motifs or poly-residues, such as MAP and poly-
arginines [21,22]. Designed peptides have been conceived on the basis
of rational mutations or combinations between protein domains of a
speciﬁc interest. TP10 is a truncated form of Transportan that
associates a neuropeptide with a segment derived from wasp
venom [23]. MPG, MPG-α and Pep-1 combine a fusion peptide or a
tryptophan-rich segment with a nuclear localization sequence [24–
26]. Finally, CADY consists of a variant of the fusion peptide JTS1 [27].
In the present work, we have investigated both the structural state
and the conformational plasticity of peptides in several distinct
environments. The structural ﬂexibility of each peptide has been
evaluated by circular dichroism (CD) spectroscopy. The amphipathic
characters for all carriers as well as their afﬁnity for different phos-
pholipids monolayer have been determined by surface physic
methods. Taken together these results enable us to identify three
classes of CPPs and to select four peptides that display common
features with the well-known MPG, Pep-1 and CADY peptides [25–
28]. The structural and binding results were combined with the
cellular uptake investigations from the literature.
2. Materials and methods
2.1. Reagents
t-Boc-protected amino acids were purchased from Neosystem
(Strasbourg, France) and Iris Biotech (Marktredwitz, Germany). 1-
Hydroxybenzotriazole, N,N′-diisopropylethylamine, N,N′-dicyclohex-
ylcarbodiimide and 4-methylbenzhydrylamine-polystyrene resin
were purchased from Iris Biotech while N,N′-dimethylformamide
from Fluka Chemie GmbH (Buchs, Switzerland). 8-Aminonaphtalene-
1,3,6-trisulfonic acid (ANTS) and his quencher p-xylene-bis-pyridinium
bromide (DPX) were purchased from Invitrogen (Cergy Pontoise,
France).
2.2. Peptides synthesis
The peptides were synthesized in a stepwise manner on an
automated peptide synthesizer (Applied Biosystems model 433A,
USA) by tert-butoxycarbonyl (t-Boc) chemistry. t-Boc amino acidswere coupled as 1-hydroxybenzotriazole (HOBt) esters in the presence
of N,N′-dicyclohexylcarbodiimide and N,N′-diisopropylethylamine on
4-methylbenzhydrylamine resin to generate C-terminally amidated
peptides.
Peptides containing His(Dnp) or Trp(For) were deprotected with
20% thiophenol in DMF for 1 h or 20% piperidine in DMF for 1 h,
respectively. Cysteine- or methionine-containing peptides were
cleaved from the resin in hydrogen ﬂuoride (HF)/p-cresol/p-
thiocresol (90/5/5) for 1 h at 4 °C, extracted with 10% aqueous acetic
acid and washed with diethylether; all other peptides were cleaved in
HF/p-cresol (90/10). Finally, the peptides were puriﬁed by semi-
preparative reverse-phase HPLC column (Discovery®BIOWide Pore C-
18, Supelco®, Sigma-Aldrich, Saint Louis, MO, USA), and their purity
checked by RP-HPLC analytical column (Discovery® C-18, Supelco®).
The correct molecular weight was veriﬁed by Perkin Elmer prOTOF™
2000 MALDI-TOF (Perkin Elmer, Sweden) mass spectrometry.
2.3. Phospholipids
Dioleoylphosphatidylcholine (DOPC) and dioleoylphosphatidyl-
glycerol (DOPG) were purchased from Avanti Polar Lipids (Alabaster,
AL, USA). Sphingomyelin (SM) and cholesterol (Chol) were purchased
from Sigma-Aldrich.
2.4. Small and large unilamellar vesicles
Small Unilamellar Vesicles (SUV) were prepared from DOPC, DOPG
or a mixture of DOPC and DOPG (80/20, m/m) by sonication. Phos-
pholipid powderwasdissolved in a chloroform/methanolmixture (3/1,
v/v). The solvent was evaporated under high vacuum for at least 3 h to
remove residual solvents. The lipidswere resuspended in purewater by
vortexmixing. The resulting lipid dispersion was sonicated in one cycle
(20 min at 70% pulse cycle in an ice/water bath) using a 450D Digital
Soniﬁer (Dietzenbach, Germany). At last, a centrifugation of the
resulting vesicles allowed the cleaning of the remaining titanium
particles from the sonication probe.
Large Unilamellar Vesicles (LUV) were prepared by the extrusion
method from a mixture of DOPC, sphingomyelin and cholesterol (40/
40/20, mol/mol/mol). The respective powder were dissolved in a
chloroform/methanol mixture (3/1, v/v) and gently mixed. The
solvent was evaporated under high vacuum for at least 3 h to remove
residual solvents. The lipids were resuspended in a 5 mM phosphate
pH 7.5 buffer by vortex mixing. Then ﬁve freeze–pump–thaw cycles
were applied and then LUV were obtained by extrusion through a
0.1 µm polycarbonate membrane (Avanti Polar Lipids). Finally, SUV
and LUV preparations were equilibrated overnight at 4 °C and used
the following day.
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The release of a substance encapsulated in liposomes is followed
by ﬂuorescence using a SPEX-PTI spectroﬂuorimeter in a 1 cm
pathlength quartz cell, with a band-pass of 2 nm for excitation and
emission. ANTS and his quencher DPX were both encapsulated in the
aqueous phase of liposomes. Liposomes were eluted on a Sephadex
G50 to remove free ANTS and DPX from medium. The ANTS ﬂuo-
rescence was measured at room temperature using excitation and
emission wavelengths at 355 and 512 nm, respectively. The liposome
leakage induces the release and dequenching of ANTS. The percentage
of release is then deﬁned as Ft/Ftot×100, where Ft is the ﬂuorescence
signal at t time and Ftot is the signal obtained after vesicle lysis with 1%
Triton X100.
2.6. Circular Dichroism (CD) spectroscopy
CD spectra were recorded on a Jasco 810 dichrograph in quartz
suprasil cells (Hellma) with an optical path of 1 mm for peptide in
solution or in the presence of small unilamellar vesicles. Same con-
centrations of peptide were used for each condition. Spectra were
obtained from three accumulations between 190 and 260 nm with a
data pitch of 0.5 nm, a bandwidth of 1 nm and a standard sensitivity.
2.7. Langmuir–Blodgett ﬁlm balance—adsorption at the air–water
interface
Adsorption studies at the air–water interface were carried out
using a homemade Langmuir trough and the surface tension was
measured with a Prolabo tensiometer (Paris, France), using the plat-
inum plate method of Wilhelmy [30]. The surface pressure measure-
mentsweremade at equilibriumafter an injection of a small amount of
the peptide-solutions into the subphase, followed by a gentle stirring
with a magnetic stirrer. The subphase consists of a NaCl 0.154 M
solution. Critical micellar concentration (CMC) was determined by
repeating this procedure until no further increase of the surface
pressure could be detected.
2.8. Langmuir–Blodgett ﬁlm balance—penetration into a phospholipid
monolayer
Regarding the penetration measurements of the peptides into the
phospholipids, a lipid monolayer was initially obtained by spreading a
solution of the lipid in chloroform/methanol (3/1, v/v) onto the air–
NaCl aqueous solution interface in order to obtain a deﬁned surface
pressure. The solvent was allowed to evaporate and when a constantFig. 1. Conformational analysis of CPPs by circular dichroism spectroscopy. The peptides were
DOPG phospholipid vesicles. The peptides are classiﬁed into three subgroups: (A) the non-o
peptides such as EB1. CD spectra are recorded for peptides at 75 µM in their free form (black)
(gray) lipid/peptide ratios. Mean molar ellipticity per residues is expressed in deg cm2 dmsurface pressure was reached, a small volume of the aqueous peptide
solution, close to the CMC, was injected into the subphase beneath the
lipid monolayer. Increase of the surface pressure was recorded for
different initial lipid surface pressures in order to identify the critical
pressure of insertion (CPI) of the peptide into the phospholipid
monolayer.3. Results
Structural properties and the secondary structure of CPPs have
recently been reported to control to a certain extent their cellular
uptake mechanism and to be associated with a speciﬁc route of entry
[31]. In the present work, we have investigated the physico-chemical
properties of 10 well known and deﬁned CPPs in order to classify
them into “biophysical” subgroups. These CPPs (PTDs, model or
chimeric peptides) have been successfully used either through
covalent or non-covalent strategies for the delivery of bioactive
cargos, and have been reported to enter cells via different pathways
(Table 1). Additionally, the YDEGE peptide, an 8-residue peptide
(YDEEGGGE-NH2) which in unable to enter cells [20], has been used
as a negative control.3.1. Structural characterization of CPPs in pure water (in their free form)
We ﬁrst investigated the conformational state of each CPP in its
free form by circular dichroism (CD) spectroscopy. As reported in
Fig. 1 and Table 2, all the CPPs presented the same CD spectra in a
solution characterized by a minimum centered at 198 nm. These
results demonstrate that all the analyzed CPPs were random coils in a
solution, despite the differences in their nature [32]. Interestingly, the
CD spectra of highly charged carriers such as Tat and Arg9 were similar
to the ones of the control YDEGE-peptide, displaying a positive
maximum at 217 nm characteristic of a full disordered structure,
generally typical for a random coil spectrum (Fig. 1) [32]. In contrast,
the CD spectra for Penetratin, TP10, MAP, EB1, pVEC, retro-pVEC,
M918 andM1073 did not show amaximum at 217 nm, suggesting the
presence of a mixture of structural conformations and a low level of
secondary structures. Similar results have also been reported for MPG,
MPG-α and CADY peptides [25,29] that are mainly random coils in a
solution. Finally, similar CD results were obtained for all the CPP-
concentrations used herein (50–150 µM), which suggests that
aggregation or auto association of the peptides are not involved.
This is in contrast to Pep-1, the only CPP able to adopt a helical
structure in pure water at high concentrations (1 mM) [28].tested in their free form and in the presence of different amounts of negatively charged
rdered peptides such as Tat, (B) the “sheet” peptides such as M918 and (C) the “helix”
and in the presence of pure DOPG vesicles at 1/1 (blue), 2/1 (red), 5/1 (green) and 10/1
ol−1.
Table 2
Structural Characterization of the CPPs.
Peptide Structurea (water) Structurea (DOPG) Structurea (DOPC/DOPG) Structurea (DOPC) Structurea (DOPC/SM/Chol) Ref.
YDEGE (control) rc rc rc rc rc –
Tat rc rc rc rc rc –
Arg9 rc rc rc rc rc –
pVEC rc β-strand/rc rc rc rc –
Retro-pVEC rc β-strand/rc rc rc rc –
Penetratin rc β-strand/rc rc rc rc –
M918 rc β-strand rc rc rc –
M1073 rc β-strand rc rc rc –
TP10 rc α-Helix α-Helix/rc rc rc –
MAP rc α-Helix α-Helix/rc rc rc –
EB1 rc α-Helix α-Helix/rc rc rc –
MPG rc β-strand/rc β-strand/rc nd nd [25,55]
MPG-α rc α-Helix/rc α-Helix/rc nd nd [25]
Pep-1 rc and α-Helix at high concentration α-Helix/rc α-Helix/rc nd α-Helix/rc [28]
CADY rc α-Helix α-Helix α-Helix/rc α-Helix [27,29]
rc: random coil.
nd: not determined.
a The main secondary structure is reported.
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phospholipids
We then investigated the impact of the presence of model
membranes on the structural state of CPPs, by using several distinct
types of liposomes (Table 2). The structure of the CPPs was de-
termined by CD in the presence of SUV containing either negatively
charged phospholipids (DOPG), neutral phospholipids (DOPC) or an
80/20 mixture of DOPC/DOPG as well as in the presence of LUV
composed of a 40/40/20mixture of DOPC/SM/Chol. The DOPC/DOPG
mixture was used in order to identify CPP structures under partially
charged conditions. The DOPC/SM/Chol LUVs were used to mimic the
composition of more stable and natural plasma membrane. As
reported in Fig. 1A and Table 2, analysis of the CD spectra reveals
that the CPPs can be classiﬁed into three subgroups based on their
secondary structure. The ﬁrst group, involving Tat, Arg9 and the
control peptide, displayed no change in the CD spectra despite the
different nature of the phospholipids or the lipid/peptide ratios used
(Fig. 1A). Indeed, the corresponding CD spectra in the presence of
DOPC, DOPG, DOPC/DOPG SUVs and DOPC/SM/Chol LUVs were
similar to those recorded for the peptides alone and characterized by a
minimum at 198 nm. These peptides showed a marked structural
polymorphism as they remained disordered in all environments
tested (Table 2).
The second group corresponds to pVEC, its retro-pVEC analogue,
Penetratin, M918 andM1073 peptides which adopted a β-structure in
the presence of negatively charged phospholipids DOPG (Table 2,
Fig. 1B). For these peptides, increasing the concentration of the
phospholipids triggered conformational changes from random coil to
β-structure. As reported for M918 in Fig. 1B, CD spectra in the
presence of DOPG were characterized by low ellipticity values and a
maximum centered around 196–198 nmwhile a single minimumwas
detected around 219 nm which is typical for β structure spectra [32].
The third group contains TP10,MAP and EB1 peptides that adopted
a helical conformational state in the presence of DOPG phospholipids
(Table 2). As shown in Fig. 1C, for the EB1 peptide, a structural
transition from a disordered structure to an α-helical conformation
occurred for a lipid/peptide ratio of 5/1. Indeed, the CD spectra
exhibited a maximum centered at 194 nm and twominima at 207 and
222 nm, which are in agreement with a main α-helical conformation
[32]. Taking into account the intensity of the band at 222 nm (around
12,500), it clearly appears that the helical domain does not involve all
the sequence but probably few residues (a third of the sequence).
These results emphasize amonomorphic behavior of these CPPs in the
presence of DOPG. Moreover, the increase in intensity of the band at222 nm for high lipid/peptide ratio suggests an increase in helical
content. The analysis of the ratio of intensities at 222 and 208 nm can
be used to distinguish helix aggregation (ratio ≥1 for coiled coils)
from monomeric helices (ratio≤0.86 for isolated helices) [33,34].
Thus the 222/208 nm ratios indicate that an aggregation of helices
probably occurs for all peptides in the presence of fully negatively
charged lipids (DOPG) while the ratio in the presence of DOPC/DOPG
mixture suggest isolated helices (as for TP10 in Fig. 2B and C).
In contrast, in the presence of the DOPC zwiterrionic liposome or
DOPC/SM/Chol (40/40/20) LUVs no conformational changes of the
CPP were observed (Table 2). The CD spectra for all the CPPs were
characterized by aminimum at 198 nm for all the lipid/peptide ratios,
indicating a random coil state as reported for TP10 in Fig. 2A and D. In
the presence of DOPC/DOPG vesicles a signiﬁcant increase of the α-
helical structural contribution was observed. Indeed the CD spectra of
TP10, MAP and EB1 underwent a slight change corresponding to a
shift of the single minimum at 198 to 205 nm associated with a
minimum at 220 nm and a maximum around 190 nm (Fig. 2B). In
contrast, no modiﬁcation in the structure of pVEC, retro-pVEC, M918
or Penetratin was observed in the mixed vesicles suggesting that
electrostatic interactions play a major role in the folding of these
peptides and that only 20% of DOPG in the vesicles is not enough to
stabilize the beta structure. With regard to the CD spectra recorded in
LUVs, the presence of sphingomyelin, cholesterol and phosphate
buffer led to similar CD proﬁles to those obtained with pure DOPC
SUVs, except for CADY that displays a helical conformational tran-
sition (Table 2). Taken together, the CD analyses in DOPC, DOPG,
DOPC/DOPG SUVs and DOPC/SM/Chol LUVs suggest that the lipid-
mediated CPP conformational transitions are mainly dependent on
electrostatic interactions, i.e. charges effect.
3.3. Afﬁnity of the CPP for air–water interface by adsorption experiments
Air–water interface constitutes a useful model to investigate the
afﬁnity of the peptides for a hydrophobic/hydrophilic interface [35].
We have therefore performed adsorption experiments in order to
determine the interfacial properties and amphipathicity of the
different CPPs [30]. The interfacial properties and the afﬁnities for a
lipid-free air–water interface of Arg9, Tat, pVEC, Penetratin, M918,
EB1, TP10 and MAP were evaluated by measuring the variation of the
surface tension as a function of the peptide concentration in the
subphase (Fig. 3). Saturation of the surface pressure was reached for
TP10, MAP, EB1 and M918, but not for Arg9, Tat, Penetratin and pVEC.
The corresponding saturating surface pressure (πsat) values for EB1
(10 mN/m), MAP (14 mN/m) and TP10 (20 mN/m) are quite similar
Fig. 2. Structural state of TP10 in various environments. Circular dichroism spectra were recorded for TP10 at 75 µM in its free form and in the presence of pure zwiterrionic DOPC
SUVs (A), mixture of DOPC/DOPG at an 80/20 ratio (B), pure negatively charged DOPG SUVs (C) and DOPC/SM/Chol LUVs (D). CD spectra correspond to pure peptide (black) and
peptide in the presence of lipid vesicles at 2/1 (blue), 5/1 (red), 10/1 (green) and 20/1 (gray) lipid/peptide ratios for DOPC, DOPC/DOPG and DOPC/SM/Chol vesicles and at 1/1
(blue), 2/1 (red), 5/1 (green) and 10/1 (gray) lipid/peptide ratios for DOPG. Mean molar ellipticity per residues is expressed in deg cm2 dmol−1.
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these peptides display a clear amphipathic character (Table 3). The
πsat value obtained for M918 (7 mN/m) is more related to that
observed for Pep-1 [28] corresponding to a less amphipathic char-
acter. However, the πsat values obtained for these CPPs are rather low
compared to the 30 mN/m recently identiﬁed for the strong
amphipathic CADY peptide [29]. Critical micellar concentration
(CMC) was determined for each peptide from variation of their
induced surface pressure and is 38, 59, 91 and 130 nM for TP10, MAP,
EB1 and M918, respectively (Table 3). These values are rather low inFig. 3. Peptide-induced variations of the surface pressures as a function of peptide
concentrations in the subphase. TP10 (1), MAP (2), EB1 (3) constituted the “helix”
peptides subgroups while M918 (4), pVEC (5) and Penetratin (6) the “sheet” subgroup,
and Arg9 (7) and Tat (8) belong to the “disordered” subgroup. No variations of the
surface pressure are detected for Penetratin, Arg9 and Tat.comparison to MPG, Pep-1 and CADY (250, 400, 500 nM) [25,28,29].
In contrast, the addition of up to 1 µM Arg9, Tat, Penetratin and pVEC
in the subphase did not induce any signiﬁcant increase in the surface
pressure, suggesting that these peptides are poorly amphipathic
(Fig. 3). When the CMC and πsat values are taken together, peptides of
the “beta-sheet” and “helix” groups can be ranked regarding to
their amphipathic character. The results clearly show that the
“helix” peptides are more amphipathic (with the following order
TP10NMAPNEB1) than the “beta-sheet” peptides, with only M918
exhibiting a weak amphipathic nature. Arg9, Tat, Penetratin and pVEC
did not display any interfacial properties.Table 3
CMC and CPI of the CPPs.
Peptide CMC
(nM)
Saturating pressure
πsat (mN/m)
CPI in DOPG
(mN/m)
CPI in DOPC
(mN/m)
Ref.
TP10 38 20 66 31 –
MAP 59 14 40 28 –
EB1 91 10 54 33 –
M918 130 7 78 23 –
Arg9 a a nd nd –
Tat a a nd nd –
Penetratin a a nd nd –
pVEC a a nd nd –
MPG 250 13 48 33 [25]
MPG-α 400 25 39 33 [25]
Pep-1 500 5 45 45 [28]
CADY 230 30 43 43 [29]
CMC: Critical micellar concentration.
CPI: Critical pressure of insertion.
nd: not determined.
a No signiﬁcant increase in the surface pressure, even at 1 µM.
Fig. 5. Insertion of MAP, TP10, M918 and EB1 into DOPG monolayers. The surface
pressure variations induced by TP10 (■), MAP (□), EB1 (●) andM918 (○) are reported
as a function of the initial pressure of the DOPG monolayer. Extrapolation at zero
pressure variation (Δπ=0) gives the critical pressure of insertion (CPI).
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measurements
The afﬁnity of the peptides for phospholipids and their ability to
insert into phospholipid ﬁlms spread at the air–water interface were
measured by monitoring the variation in surface tension and by using
different initial pressures associated with an injection of the peptides
in the subphase. [30,36]. The peptide concentration used here was
slightly lower than its CMC [37]. Critical pressures of insertion (CPI)
were then determined by extrapolation of the initial surface pressure
for a variation of surface pressure equal to zero (πi for Δπ=0). As for
the CD analysis, we have compared two types of lipid monolayers, i.e.
negatively charged phospholipids (DOPG) and neutral phospholipids
(DOPC). Since Arg9, Tat, Penetratin and pVEC presented no interfacial
properties, we focused on the TP10, MAP, EB1, M918 peptides and the
results were compared to the previously analyzed CPPs MPG, Pep-1
and CADY (Table 3).
The CPI values for EB1, TP10 andMAPwere estimated to be around
30 mN/m (33, 31 and 28 mN/m, respectively) for DOPC monolayer,
suggesting that these peptides are able to insert spontaneously into
the phospholipid monolayer and into biological membranes (CPI
values N30–35 m/M) [36,38] (Table 3, Fig. 4). Their afﬁnity for the
lipid ﬁlm is close to that of MPG and MPG-α (33 mN/m) but rather
lower compared to CADY and Pep-1 (43 and 45 mN/m, respectively).
The CPI value obtained forM918 in DOPC is lower (23 mN/m) than for
the other CPPs [25,28,29], indicating aweaker insertion of this peptide
into the DOPCmonolayer as already suggested by the CD experiments.
In addition, information on interactions between the peptides and the
phospholipids can be evaluated by extrapolation of the variation of
the surface pressure at zero initial pressure (Δπ for πi=0) where
surface pressures higher than the peptides πsat generally suggest
strong peptide–lipid interactions [30]. In the case of the DOPC
monolayers, the extrapolated values are quite similar to πsat for all
the peptides except for EB1 that displays a little deviation around
4 mN/m from πsat (Fig. 4). These observations indicate that the “helix”
peptides are able to insert into the monolayer of the neutral
phospholipid DOPC with weak interactions while M918 is not. The
order of interaction is EB1NTP10NMAP.
In contrast, all the evaluated peptide showed a better afﬁnity for
the DOPG monolayers, with extrapolated CPI values higher than
40 mN/m, clearly indicating a better insertion of all peptides in this
monolayer compared to DOPC (Table 3, Fig. 5). Furthermore, these
high CPI values suggest that the peptides can spontaneously insert
into natural membranes (CPI values N30–35 m/M) [36,38]. Interest-
ingly, M918 strongly interacts with the negatively charged phospho-
lipids with a high CPI value of 78 mN/m extrapolated for Δπ=0 and aFig. 4. Insertion of MAP, TP10, M918 and EB1 into DOPC monolayers. The surface
pressure variations induced by TP10 (■), MAP (□), EB1 (●) andM918 (○) are reported
as a function of the initial pressure of the DOPC monolayer. Extrapolation at zero
pressure variation (Δπ=0) gives the critical pressure of insertion (CPI).variation of surface pressure at zero initial pressure (Δπ for πi=0) of
15 mN/m. This is twice the πsat value, suggesting strong peptide/lipid
interactions. A high CPI value of 66 mN/mwas also obtained for TP10.
However, the extrapolation of the surface pressure for πi=0 was
similar to the πsat (20 mN/m), suggesting that the peptide/lipid
interaction was weaker than for M918 (Fig. 5). MAP and EB1 were
able to insert into the phospholipids monolayer, with CPI values
which are quite close to those previously measured for MPG, MPG-α,
Pep-1 and CADY (Table 3). Nevertheless, the Δπ value for EB1 at πi=0
is 2.5 fold higher than its πsat, suggesting stronger peptide/lipid
interaction than in the case of MAP (Δπ=πsat for πi=0). Taken
together, these results indicate that all the peptides strongly interact
with the charged phospholipids DOPG with the following order of
interaction M918NTP10NEB1NMAP, but their interaction with neu-
tral phospholipids is limited. Finally, the different results (CPI and Δπ
for πi=0) obtained for the penetration experiments in the presence of
DOPC and DOPG monolayer indicate slightly distinct behavior
between the tested peptides. The CPI values for TP10, MAP, M918
and EB1 are higher in DOPG than in DOPC, indicating that strong
electrostatic effect could affect their insertion into the lipid mono-
layer. This electrostatic effect seems to bemore pronounced for M918.
In order to assess the consequence of CPP/membrane interactions
onmembrane stability, we have carried out leakage tests by following
dye-release from pre-loaded LUVs. Results reported in Table 4,
revealed that several of the peptides, identiﬁed as being able to
interact with membrane, also induce leakage. The net increase (70%)
of the ANTS ﬂuorescence observed in the presence of MAP suggests a
strong membrane disruption and conﬁrms its bilayer insertion and
membrane-destabilizing activity as already reported (Table 4). CADY
and EB1 induced a moderate leakage (30–40%) and ANTS leakage
values obtained for TP10, M918, Penetratin and Tat (10%), reveal that
these peptide have a poor tendency to destabilize membrane. FinallyTable 4
Leakage of liposomes induced by CPPs monitored by ﬂuorescence spectroscopy. The
peptide concentration used is 1 µM and the lipid/peptide molar ratio is 40/1.
Peptides % of leakage after 15 min
MAP 70
CADY 38
EB1 26
TP10 12
M918 12
Penetratin 9
Tat 8
pVec 2
Arg9 1
1125E. Eiríksdóttir et al. / Biochimica et Biophysica Acta 1798 (2010) 1119–1128pVec and Arg9 did not induce any leakage, suggesting no membrane
perturbation and probably no insertion into the liposome bilayer. That
MAP, CADY, EB1 and to a certain extend TP10, and M918, are able to
induced membranes destabilization, correlated with phospholipids
monolayer penetration measurements, supporting a net membrane
insertion of MAP, CADY and EB1 and a less marked insertion for TP10
and M918.
4. Discussion
During the last two decades, cell-penetrating peptides have
become promising tools for the intracellular delivery of therapeutics
[31]. These peptide-carriers were developed in the beginning to cross
the plasma membrane and reach the nucleus. Today, the number of
optimized CPPs is constantly increasing in the search of improved
efﬁcacy, intracellular routing and speciﬁc tissues targeting. CPPs can
be subdivided into two main classes, the ﬁrst requiring chemical
linkage with the cargo, and the second involving formation of stable,
non-covalent complexes, which appears to be more appropriate for
charged cargos such as siRNAs [1,39]. Although CPPs have been
extensively used in vitro, in vivo andmore recently at the clinical level,
the mechanism by which they are able to deliver active cargoes inside
the cell constitutes a complicated “brain-teaser” and remains the
quest to the “Holy grail”. In numerous cases, the cellular uptake the
CPPs and the cargo-related biological response cannot be fully
explained by endosomal routes triggered or not by electrostatic in-
teractions with cell surface proteoglycans. Recently, structural
properties and the ability of CPPs to interact with the lipid phase of
the membrane have been reported to play a major role in the cellular
uptake mechanism and the mode of action of CPPs. Comparative
analysis of CPPs which have been reported so far, were focused on the
delivery of covalently linked ﬂuorophores [40] or biologically relevant
cargo [41]. In the present work, we report the ﬁrst comparative study
of the structural plasticity of 10 well-known CPPs and their ability to
interact with phospholipid membranes. We showed that the
interaction of CPP with the membrane involves mainly electrostatic
interactions and triggers a conformational transition of the peptides
from random coil to helical or beta forms. We demonstrate that CPPs
can be classiﬁed into three subgroups depending on their physico-
chemical properties, which correspond to distinct internalization
pathways already reported in the literature.
4.1. Structural plasticity of the CPPs: polymorphism vs. monomorphism
The identiﬁcation of the folding properties of the CPPs is clearly a
major step for the understanding of their mode of action and has
revealed that CPPs can adopt speciﬁc conformations, which are
essential for membrane interactions and internalization. Analysis of
the conformation of CPPs in different lipid mimicking environments
by circular dichroism has allowed their classiﬁcation into three
distinct subgroups (Table 2, Fig. 1). The “disordered” subgroup
contains cationic peptides such as Tat and Arg9, which are fully
polymorphic and unable to adopt any speciﬁc secondary structure
whatever the nature of their environment. Tat and Arg9 display no
structural changes and remain disordered in the presence of
phospholipids as already reported by several groups [42,43]. Although
the folding of Tat has been discussed in numerous work so far no
speciﬁc conformation has been clearly identiﬁed [43,44]. The peptides
TP10, MAP, EB1, MPG-α, CADY and Pep-1 form the “helical” subgroup
characterized by structural transition from a random coil (poly-
morphic behavior) in a solution to α-helix (monomorphic structure)
in the presence of phospholipids. In contrast to TP10 and EB1 for
which no structural data have been reported so far, the secondary
amphipathic α-helical structure of MAP peptide has already been
observed in the presence of different media [45,46]. The identiﬁcation
of an α-helix conformation for TP10 and EB1 is in a perfect agreementwith previously reported theoretical predictions. Amphipathic helix
structure was predicted in silico for TP10 based on the fact that it
derived from Mastoparan segment known to be an amphipathic α-
helix [23,47]. The EB1 sequence was derived from Penetratin by
substituting residues 1 and 4 to histidines and extending the N-
terminus with six amino acids in order to promote a helical struc-
ture [18]. This “helix” subgroup of CPPs can be extended to CADY [29],
Pep-1 [26] and MPG-α [25] peptides which also undergo a helical
structural change (Table 2). Although MPG-α and Pep-1 are able to
fold partially into a helix at high concentrations in a solution, their α-
ellipticity is dramatically increased in the presence of phospholipids
or SDS [25,28]. The helical contributions involve few residues of the
peptide, suggesting a speciﬁc localization of the helix inside the
sequence. Although an amphipathic distribution can be considered for
MAP [21], CADY [27], Pep-1 [28] and the mastoparan domain of TP10
(as reported in [23]), the constitution of a secondary amphipathic
helix is less straightforward for EB1. In addition, peptides of the
“helix” group undergo an increase of their helical content in the
presence of negatively charged vesicles, suggesting helix association.
This could be due to both amphipathic feature and electrostatic
effects. Although the helical domains seem to involve few residues of
the sequence, they might induce speciﬁc amino acids distribution
leading to helix aggregation through intermolecular interactions.
Finally, the peptides pVEC, retro-pVEC, M918, M1073, Penetratin
and MPG constitute the “sheet” subgroup characterized by a
phospholipid-mediated conformational transition from a disordered
state to a β-sheet structure. The structural state of Penetratin seems to
be highly dependent on the experimental conditions including the
nature of the lipids and the phospholipid polar heads, buffers, con-
centrations and the technique used [48,49]. The structural versatility
of Penetratin from unfolded to a β-sheet structure has been reported
in the presence of negatively charged phospholipids [48,50,51 and
this work], and to a helical-structure in various environments [43,52–
55]. Concerning MPG, several spectroscopic analyses reveal a
predominantly β-sheet structure in the presence of lipids vesicles
and membrane mimicking solvents [56].
4.2. Helical structure is associated with strong CPP-membrane
interactions
We showed that several CPPs can adopt a speciﬁc secondary
structure, which play a major role in stabilizing their interactions with
membranes and promoting their cellular uptake. During the inter-
nalization process, whether at the cell surface or inside endosomal
vesicles or speciﬁc intracellular compartments, CPP/lipid interactions
take place. We demonstrate that only few CPPs exhibit a signiﬁcant
afﬁnity for the hydrophobic/hydrophilic interface. Tat and Arg9
cationic CPPs as well as Penetratin and pVEC exhibited no afﬁnity
for the air–water interface for all the conditions and concentrations
used .However the lack of afﬁnity for interface does not indicate a lack
of interactions. Penetratin and Arg9 peptides have been reported to
interact with negatively charged phospholipids [57,58]. In contrast,
TP10, MAP, EB1 and M918 are the most amphipathic peptides; they
strongly interact with DOPG, but only peptides from the “helix” group
(TP10, MAP and EB1) are able to insert spontaneously into DOPC lipid
monolayer. The CPI values suggest that TP10, MAP, EB1 and M918 are
able to spontaneously insert into biological membranes mainly
throughout strong electrostatic interactions with the polar heads of
lipids rather than hydrophobic contacts with the lipids. In addition,
there is a direct impact of the secondary structure that modulates the
amphipathicity and membrane interaction/insertion of the CPPs.
Indeed, negatively charged vesicles induced peptides conformational
changes that were stronger than for zwiterrionic liposomes. This
behavior highlights the importance of electrostatic interactions as
already described for other peptides such as S413-PV [59]. Structural
analyses of the peptide/lipid interactions indicate that peptides
1126 E. Eiríksdóttir et al. / Biochimica et Biophysica Acta 1798 (2010) 1119–1128adopting a β-structure, such as M918 and MPG, are more sensitive to
charges than the helical ones. Such a behavior differs from other CPPs
for which a combination of electrostatic and hydrophobic interactions
was identiﬁed. Indeed, for Pep-1 and CADY, the interactions with the
lipids involved both electrostatic and hydrophobic contributions
[28,29]. Thus helical peptides, such as TP10, EB1, MAP—and by
extension MPG-α, Pep-1 and CADY—seem to have a higher potential
for peptide/lipids interactions, than β-structured MPG and M918
peptides.
Finally two additional points have to be considered: membrane
stability and the location of the peptide within the membrane.
Membrane leakage investigation has revealed that CPPs, which are
able to insert into lipid monolayer and to adopt helical secondary
structure, can induce a more or less pronounced membrane
disruption. Although some of them consists in well deﬁned secondary
amphipathic peptide (MAP, CADY and TP10), it seems that the
observed membrane perturbation cannot be clearly associated to the
amphipathicity. Indeed EB1 that is less amphipathic than TP10
induces a better leakage. With regard to the peptide membrane
insertion, although monolayer approaches seem to support an
embedded location of carriers in themembrane, none straightforward
conclusion can be pronounced. Only orientated CD, neutron diffusion
or ATR-infra-red spectroscopy could distinguish a quasi-horizontal
planar orientation compared to a vertically or tilted insertion.4.3. Does structural versatility of CPP control/impact internalization
pathway?
Nowadays, it is clearly admitted that the ﬁrst step in the cellular
entry of CPPs corresponds to electrostatic interaction with cell surface
proteoglycans, even if it is not a prerequisite for the cellular uptake.
Interaction with GAG induces their clustering at the cell surface and
triggers activation of intracellular signals/actin remodeling and cell
entry throughout numerous distinct internalization pathways ranging
from direct translocation to endocytotic processes [14,41,60]. Thus
the second determinant step mainly consists of peptide/lipid
interactions that can lead both to the induction of a speciﬁc
endocytotic pathway or to a membrane perturbation. In this regard,
a conformational change, as identiﬁed for “sheet” and “helix”Fig. 6. A model of different lipid interaction abilities of Cpeptides, can modulate peptides/lipids interactions. The strength of
these interactionsmight then determinewhether the peptides remain
entrapped at the plasma membrane or not; and then whether the
peptides follow an endocytotic route or induce membrane disorga-
nization with direct translocation. As already mentioned, whether at
the plasma membrane or inside endosomal vesicles, the nature of
peptide/lipid interactions will determine the intracellular future of
CPPs.
It has been proposed that the cellular internalization of the
peptides could differ depending on their amphipathicity and poly-
cationic nature, [41] and that the sequence length and conformation
have a more important role than the accumulation of positive charges
[40]. Furthermore, the structural versatility has been described as an
important factor to consider for the deciphering of the cellular uptake
of CPPs [51,59,61]. The present work support the idea that the
structural plasticity could have a crucial role since inducing a speciﬁc
amino acids distribution through a conformational change. This spatial
reorganization allows a new balance between hydrophobic and
hydrophilic surfaces with a speciﬁc charges distribution all along the
conformation. Therefore CPPs modiﬁed their apparent hydrophilic/
hydrophobic domains depending on the environment and on the
nature of their peptide/lipid interactions [47,51 and this work]. We
believe that the analysis of biophysical aspects needs a step by step
approach that begins by the identiﬁcation of intrinsic properties of the
peptides. We sum up the structural and interaction properties of the
different CPPs and proposed a model to classify the peptides regarding
to their intrinsic biophysical features and their main internalization
pathways (Fig. 6). The versatility of some CPPs should lead to both
direct translocation and endocytotic process while the pronounced
polymorphism of the others only induces an endocytotic mechanism.
The strength and nature of peptide/lipids interactions will then de-
termine the internalization mechanism.Acknowledgements
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